Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma

JOURNAL ARTICLE published 4 March 2021 in New England Journal of Medicine

Authors: Toni K. Choueiri | Thomas Powles | Mauricio Burotto | Bernard Escudier | Maria T. Bourlon | Bogdan Zurawski | Victor M. Oyervides Juárez | James J. Hsieh | Umberto Basso | Amishi Y. Shah | Cristina Suárez | Alketa Hamzaj | Jeffrey C. Goh | Carlos Barrios | Martin Richardet | Camillo Porta | Rubén Kowalyszyn | Juan P. Feregrino | Jakub Żołnierek | David Pook | Elizabeth R. Kessler | Yoshihiko Tomita | Ryuichi Mizuno | Jens Bedke | Joshua Zhang | Matthew A. Maurer | Burcin Simsek | Flavia Ejzykowicz | Gisela M. Schwab | Andrea B. Apolo | Robert J. Motzer